Sign in | Register
Services
Solutions
About Us
Resources
Contact Us
aidd-banner-m2

From AI Design to IND-Ready Candidates

Helping biotech and pharmaceutical companies bridge the gap between AI-generated antibody sequences and IND-enabling development. The platform combines wet lab validation using high-throughput screening, developability assessment, pharmacology studies, and accelerated CMC activities within a single integrated workflow.
Our Services
Workflow
Why ProBio
Solutions
FAQs
Contact Us

Test Faster. Advance Better Candidates.

Generate more value from every AI-designed sequence through integrated wet-lab validation and AI-ready data.
AI generates thousands of antibody sequences optimized using wet lab design-build-test-learn cycles. ProBio bridges the gap from AI generated sequences to functional, validated, developable leads through high-throughput screening, and an integrated  pharmacology platform, from antibody expression to toxicology.

Identify True Functional Hits Early​

Validate functionality, developability, and biological relevance to confidently select the candidates most likely to succeed.
Move beyond sequence prediction and binding data alone. Assess functionality, developability, and biological relevance through tailored in vitro and in vivo testing strategies, expert scientific interpretation, and ready-to-use assays and animal models, generating the high-quality validation data needed for confident candidate selection.

From Candidate Selection to IND Readiness

Accelerate Preclinical Candidate (PCC) selection, reduce CMC risk, and move promising candidates to IND faster.
Once the right candidates emerge, accelerate their path to the clinic. Combining our high performing CHO K1 cell line and ProMax™ vector to accelerate process development, reduce CMC risk, and deliver Tox DS in as little as 4.5 months from transfection, even for complex molecules, enabling faster advancement to IND.
Years of Deep Expertise in Biologics Discovery
Projects in Therapeutic Antibody
Projects in the Clinical Phase and Marketed

AI models move fast. Validation shouldn’t be the bottleneck

AI can generate thousands of antibody candidates, but finding the few with real therapeutic potential remains a critical bottleneck. ProBio bridges the gap between AI prediction and therapeutic reality through integrated validation, developability assessment, pharmacology, and CMC solutions, enabling faster selection of development-ready candidates and accelerating the path to the clinic.

AIDD solution workflow A three-stage workflow progressing from AI sequence screening through wet-lab validation to IND-enabling CMC service. SelectProve OptimizeAdvance Wet-Lab functionalvalidation serviceSample prep & CMCdevelopability service IND-enabling CMC service ScreenValidateAdvance

AIDD Solutions workflow 2A five-stage antibody screening funnel paired with integrated-platform, high-throughput, screening-strategy, and AI-ready-data benefits. 107–8105–6102–3101–21–5 01Antibody Design andGeneration02Primary Screening03HTP Screening 04In VitroBioassay05In VivoStudy Learn Integrated Platform • Expression to PK/Tox, all in one workflow • Seamless program progression • Zero handoff friction, faster decisions Fast & High-Throughput • 10-day turnaround from gene to data • Automated high-throughput screening • Hundreds of samples processed daily Comprehensive Screening Strategy • Balancing Functionality and Developability • Established assays and animal models AI-Ready Data • Customized, AI-ready data outputs • Flexible reporting formats • Optimized for model training

Actionable Insights in as Fast as 10 Days

Integrated DNA-to-LNP Platform

Integrated Platform

Our integrated discovery platform streamlines the journey from expression through PK/Tox evaluation within a single workflow, enabling seamless program progression without the delays and complexity of multiple vendor handoffs. By consolidating critical development activities into one platform, teams can make faster, more informed decisions and accelerate candidate advancement.
Icon: Fast, high-throughput screening with AI-ready data outputs - scalable biologics discovery platform

Fast, High-Throughput & AI-Ready Data

Designed for speed and scalability, ProBio's platform delivers actionable insights in as little as 10 days from gene to data. Automated workflows enable high-throughput screening, accelerating candidate evaluation without compromising data quality. Customized, AI-ready datasets and flexible reporting formats provide the structured insights needed to power advanced analytics, refine predictive models, and support confident, data-driven decision-making.
Icon: Proven biologics discovery expertise with validated assays and developability screening

Proven Discovery Expertise

Backed by extensive discovery experience, our team helps identify high-potential candidates through comprehensive functionality and developability screening. Established assays and validated animal models provide reliable data to assess key attributes early, reducing development risk and supporting confident progression toward clinical development.

Tailored to Your Workflows

Actionable Data in Under 10 Days

Actionable Data in Under 10 Days

High-Throughput Functional Screening Identifies High-Quality Bispecific Antibody Leads in Days.
From Sequence to Tox-Ready Material in 4.5 Months

From Sequence to Tox-Ready Material in 4.5 Months

From AI Sequence to Pre-Tox in 4 Months: Accelerating Developability and CMC Readiness with PrepCMC and ExpressCMC.
Reducing Time to Tox-Ready Material

Reducing Time to Tox-Ready Material

Accelerating Biologics CMC Development with Integrated Cell Line, Process, and Formulation Platforms.

Frequently Asked Questions

Turn your AI-generated candidates into developable drug assets

Turn Your AI-Generated Candidates into Developable Drug Assets

Talk to our experts about your development, manufacturing, and CMC needs.

Talk to Our Experts